Contributions present research on how health innovations are developed, evaluated, adopted, and scaled across settings and globally - including pharmaceuticals/biotech, medical devices, diagnostics, digital health and AI, and organizational/service innovations - using economic and behavioral approaches.

Topics include innovation incentives and market design; regulation, pricing/reimbursement and procurement; IP, competition and entry; evidence generation and clinical trials; and economic evaluation/HTA, particularly where it informs innovation, value, adoption, and real-world implementation.

Contributions also present research on behavioral drivers and barriers to diffusion (e.g., provider prescribing and practice patterns, patient uptake and adherence, trust and information environments, and organizational decision-making) and on data- and platform-driven innovation (algorithms, digital therapeutics, AI-enabled diagnostics, and learning health systems), including work on access, affordability, and public-good innovation models (e.g., open science, platform public goods, and innovations for underserved populations).

Potential topics

• Innovation incentives and market design
• Regulation, pricing/reimbursement and procurement
• IP, competition and entry
• Evidence generation and clinical trials
• Economic evaluation and HTA
• Behavioral drivers and barriers to diffusion including provider prescribing patterns, patient uptake and adherence, trust and information environments
• Organizational decision-making
• Data- and platform-driven innovation including algorithms, digital therapeutics, AI-enabled diagnostics, and learning health systems
• Access and affordability
• Public-good innovation models including open science, platform public goods, and innovations for underserved populations

Timeline

• Invalid DateTime: Submission deadline